ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea · Delayed Price · Currency is KRW 139,500
+12,700 (10.02%)
May 22, 2026, 3:30 PM KST
ST Pharm Market Cap
ST Pharm has a market cap or net worth of 2.91 trillion as of May 22, 2026. Its market cap has increased by 88.11% in one year.
Market Cap
2.91T
Enterprise Value
2.90T
Revenue
331.68B
Ranking
n/a
PE Ratio
51.89
Stock Price
139,500.00
Market Cap Chart
Since June 23, 2016, ST Pharm's market cap has increased from 902.04B to 2.91T, an increase of 222.35%. That is a compound annual growth rate of 12.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 2.64T | 7.11% |
| Dec 30, 2025 | 2.47T | 37.85% |
| Dec 30, 2024 | 1.79T | 40.37% |
| Dec 28, 2023 | 1.28T | -22.60% |
| Dec 29, 2022 | 1.65T | -36.55% |
| Dec 30, 2021 | 2.60T | 34.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.58T |
| Celltrion | 39.74T |
| ALTEOGEN | 19.50T |
| Samsung Epis Holdings | 12.07T |
| CLASSYS | 3.13T |
| SK bioscience | 3.12T |
| PharmaResearch | 3.05T |
| OliX Pharmaceuticals | 2.97T |